Pandemic pushing risky activities into healthcare data management

The COVID crisis has significantly increased the volume of data healthcare providers are rushing into the cloud. This “smash and grab” behavior is largely explained by the spike in healthcare workers doing their jobs remotely.

Also on the rise are “smuggler” activities, a catchy name for consolidation of large data stores from providers’ internal servers to unexpected external systems.

While neither of these actions are necessarily perilous in and of themselves, both are exploitable by nefarious actors.

The findings and commentary come from Vectra AI, a cybersecurity concern based in San Jose. The company released a report June 30, stating it drew on observations from a sample of 363 opt-in organizations in healthcare and eight other industries.

The report also shows North America, along with Europe, the Middle East and Africa, experiencing increases in external data movement, or “exfiltration,” consistent with cloud migration.

In a news release publicizing the report, Vectra security head Chris Morales says cloud computing optimizes resource allocation in healthcare—but also exposes sensitive data to considerable risks.

“This is especially true when cloud adoption happens faster than proper due diligence can be applied by information security personnel,” Morales says. “This trend will persist well after the pandemic.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.